Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Lower limb hyperreflexia, Unsteady gait, and Spastic paraplegia; and common findings: Babinski sign, Gait ataxia, and Muscle spasm. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Paresthesia, Difficulty swallowing (dysphagia), Babinski sign |
HPDL encodes 4-hydroxyphenylpyruvate dioxygenase like (371 aa). Iron-dependent dioxygenase that catalyzes the conversion of 4-hydroxyphenylpyruvate (4-HPPA) to 4-hydroxymandelate (4-HMA) in the mitochondria, one of the steps in the biosynthesis of coenzyme Q10 fro... Highest expression in Cells EBV-transformed lymphocytes (12.6 TPM) and Brain Cerebellar Hemisphere (8.7 TPM).
Spastic paraplegia 83, autosomal recessive is associated with mutations in the HPDL gene on chromosome 1.
The HPDL protein participates in HPDL dioxygenates HPPA and Ubiquinol biosynthesis pathways.
HPDL is classified as a druggable target with score 0.0.
Genetic testing for HPDL is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spastic paraplegia 83, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic paraplegia 83, autosomal recessive.
7 publications have been identified in PubMed for spastic paraplegia 83, autosomal recessive. Research spans Review / Meta-Analysis (29%), Diagnostic / Biomarker (14%), and Case Report / Case Series (14%).
Safka Brozkova D (2026). [PMID: 41749354](https://pubmed.ncbi.nlm.nih.gov/41749354/). *Hum Genomics*. [Diagnostic / Biomarker]
Fiscal-Carvajal AB (2026). [PMID: 42175574](https://pubmed.ncbi.nlm.nih.gov/42175574/). *Mov Disord Clin Pract*. [Case Report / Case Series]
Vaghefi F (2026). [PMID: 42116150](https://pubmed.ncbi.nlm.nih.gov/42116150/). *BMC Med Genomics*. [Review / Meta-Analysis]
Di Folco C (2025). [PMID: 40832806](https://pubmed.ncbi.nlm.nih.gov/40832806/). *Movement disorders : official journal of the Movement Disorder Society*. [Clinical Trial Publication]
Alecu JE (2025). [PMID: 39731469](https://pubmed.ncbi.nlm.nih.gov/39731469/). *Genet Med*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Muscles
2 |
Muscle spasm, Myalgia |
Digestive system | 1 | Difficulty swallowing (dysphagia) |
Kidneys and urinary system | 1 | Urinary urgency |
Arms and legs | 1 | Lower limb hyperreflexia |
Age of onset: adolescence.
Erkan DD (2025). [PMID: 40827465](https://pubmed.ncbi.nlm.nih.gov/40827465/). *Int J Dev Neurosci*. [Review / Meta-Analysis]
Baggiani M (2024). [PMID: 39408944](https://pubmed.ncbi.nlm.nih.gov/39408944/). *Int J Mol Sci*. [Basic Science / Preclinical]